Name | Number of supported studies | Average coverage | |
---|---|---|---|
type I pneumocyte | 12 studies | 36% ± 13% | |
type II pneumocyte | 12 studies | 47% ± 14% | |
epithelial cell | 5 studies | 42% ± 11% | |
club cell | 5 studies | 36% ± 11% | |
astrocyte | 5 studies | 21% ± 5% | |
endothelial cell | 4 studies | 20% ± 2% | |
retina horizontal cell | 4 studies | 26% ± 6% | |
fibroblast | 4 studies | 20% ± 2% | |
ciliated cell | 3 studies | 19% ± 3% | |
GABAergic neuron | 3 studies | 31% ± 3% | |
glutamatergic neuron | 3 studies | 38% ± 5% | |
oligodendrocyte precursor cell | 3 studies | 25% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 100% | 3091.62 | 578 / 578 | 100% | 53.47 | 1153 / 1155 |
ovary | 100% | 1420.96 | 180 / 180 | 100% | 22.85 | 428 / 430 |
brain | 100% | 984.73 | 2639 / 2642 | 99% | 30.69 | 699 / 705 |
esophagus | 100% | 977.55 | 1445 / 1445 | 98% | 20.25 | 180 / 183 |
thymus | 100% | 3918.10 | 653 / 653 | 98% | 96.49 | 594 / 605 |
prostate | 100% | 995.92 | 245 / 245 | 97% | 18.02 | 489 / 502 |
intestine | 100% | 1049.61 | 966 / 966 | 94% | 16.94 | 497 / 527 |
pancreas | 99% | 548.65 | 324 / 328 | 96% | 19.74 | 170 / 178 |
breast | 100% | 1184.09 | 459 / 459 | 94% | 15.01 | 1053 / 1118 |
adrenal gland | 100% | 1230.60 | 258 / 258 | 94% | 17.10 | 216 / 230 |
stomach | 100% | 1858.49 | 359 / 359 | 93% | 16.49 | 266 / 286 |
uterus | 100% | 1286.57 | 170 / 170 | 93% | 18.16 | 426 / 459 |
kidney | 100% | 1008.38 | 89 / 89 | 91% | 13.84 | 821 / 901 |
skin | 100% | 1334.25 | 1809 / 1809 | 91% | 16.07 | 429 / 472 |
bladder | 100% | 937.86 | 21 / 21 | 89% | 16.84 | 448 / 504 |
liver | 100% | 739.75 | 226 / 226 | 79% | 9.45 | 322 / 406 |
adipose | 100% | 1072.47 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 14.08 | 29 / 29 |
spleen | 100% | 793.85 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 7.21 | 1 / 1 |
blood vessel | 100% | 1325.47 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 94% | 446.32 | 809 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 93% | 13.82 | 42 / 45 |
eye | 0% | 0 | 0 / 0 | 71% | 9.93 | 57 / 80 |
muscle | 64% | 203.04 | 512 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 29% | 373.81 | 267 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0046330 | Biological process | positive regulation of JNK cascade |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0045995 | Biological process | regulation of embryonic development |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_0051726 | Biological process | regulation of cell cycle |
GO_0051302 | Biological process | regulation of cell division |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0090043 | Biological process | regulation of tubulin deacetylation |
GO_0072686 | Cellular component | mitotic spindle |
GO_0005730 | Cellular component | nucleolus |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0140672 | Cellular component | ATAC complex |
GO_0004860 | Molecular function | protein kinase inhibitor activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0005515 | Molecular function | protein binding |
Gene name | MBIP |
Protein name | MAP3K12 binding inhibitory protein 1, isoform CRA_b (cDNA, FLJ96307, Homo sapiens MAP3K12 binding inhibitory protein 1 (MBIP), mRNA) MAP3K12 binding inhibitory protein 1 MAP3K12-binding inhibitory protein 1 (MAPK upstream kinase-binding inhibitory protein) (MUK-binding inhibitory protein) |
Synonyms | BM-015 hCG_20993 |
Description | FUNCTION: Inhibits the MAP3K12 activity to induce the activation of the JNK/SAPK pathway. Component of the ATAC complex, a complex with histone acetyltransferase activity on histones H3 and H4. . |
Accessions | ENST00000318473.11 [Q9NS73-5] ENST00000603139.1 ENST00000604160.1 ENST00000416007.9 [Q9NS73-1] ENST00000604336.5 ENST00000605579.5 ENST00000359527.11 [Q9NS73-3] S4R3Y0 B2RCV0 S4R3N2 Q9NS73 S4R2X9 S4R3P6 |